Invention Grant
US07674453B2 Tumor necrosis factor combined with interferon in demyelinating diseases
失效
肿瘤坏死因子与干扰素联合在脱髓鞘疾病中
- Patent Title: Tumor necrosis factor combined with interferon in demyelinating diseases
- Patent Title (中): 肿瘤坏死因子与干扰素联合在脱髓鞘疾病中
-
Application No.: US10503525Application Date: 2003-01-29
-
Publication No.: US07674453B2Publication Date: 2010-03-09
- Inventor: Giampiero de Luca
- Applicant: Giampiero de Luca
- Applicant Address: CH Aubonne
- Assignee: Ares Trading SA
- Current Assignee: Ares Trading SA
- Current Assignee Address: CH Aubonne
- Agency: Saliwanchik, Lloyd & Saliwanchik
- Priority: EP02100110 20020206
- International Application: PCT/EP03/50006 WO 20030129
- International Announcement: WO03/066165 WO 20030814
- Main IPC: A61K45/00
- IPC: A61K45/00 ; A61K38/21 ; A61K39/00 ; A61K38/16
Abstract:
The invention relates to the use of an agent having, stimulating or maintaining tumor necrosis factor (TNF) activity, together with an interferon (IFN) for treating and/or preventing demyelinating diseases, in particular multiple sclerosis (MS). The use of a combination of a TNF or a tumor necrosis factor binding protein in combination with an interferon for treating and/or preventing demyelinating diseases is preferred.
Public/Granted literature
- US20050142100A1 Tumor necrosis factor combined with interferon in demyelinating diseases Public/Granted day:2005-06-30
Information query
